Amy L. Burroughs Dia Medica Therapeutics Inc. (DMAC) insider trading activity

DMAC Quotes by TradingView

Amy L. Burroughs is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 73,288 shares of DMAC, which is worth approximately $382,563. The most recent transaction as insider was on Jan 03, 2023, when has been sold 17,156 shares (Voting Common Shares, no par value per share) at a price of $1.53 per share, resulting in proceeds of $26,248. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.3K
0% 3M change
0% 12M change
Total Value Held $382,563

Amy L. Burroughs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
BUY
Grant, award, or other acquisition
$26,248 $1.53 p/Share
17,156 Added 18.97%
73,288 Voting Common Shares, ...
Jan 03 2022
BUY
Grant, award, or other acquisition
$40,032 $3.58 p/Share
11,182 Added 16.61%
56,132 Voting Common Shares, ...
Aug 16 2021
BUY
Open market or private purchase
$141,593 $3.15 p/Share
44,950 Added 50.0%
44,950 Voting Common Shares, ...

Also insider at

TNYA
Tenaya Therapeutics, Inc. Healthcare
TERN
Terns Pharmaceuticals, Inc. Healthcare
Chief Executive Officer
ALB

Amy L. Burroughs

Director
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMAC